dc.creatorOrellano, Pablo Wenceslao
dc.creatorSalomón, Oscar Daniel
dc.date.accessioned2018-05-28T15:49:21Z
dc.date.accessioned2018-11-06T14:46:23Z
dc.date.available2018-05-28T15:49:21Z
dc.date.available2018-11-06T14:46:23Z
dc.date.created2018-05-28T15:49:21Z
dc.date.issued2016-06
dc.identifierOrellano, Pablo Wenceslao; Salomón, Oscar Daniel; Will dengue vaccination be cost-effective for Argentina? Reply to letter by Urueña et al. regarding “Cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission”; Elsevier; Vaccine; 34; 28; 6-2016; 3221
dc.identifier0264-410X
dc.identifierhttp://hdl.handle.net/11336/46248
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1890096
dc.languageeng
dc.publisherElsevier
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/https://dx.doi.org/10.1016/j.vaccine.2016.03.105
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0264410X16301025
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectARGENTINA
dc.subjectCOST UTILITY ANALYSIS
dc.subjectDENGUE
dc.subjectDENGUE VACCINES
dc.titleWill dengue vaccination be cost-effective for Argentina? Reply to letter by Urueña et al. regarding “Cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission”
dc.typeArtículos de revistas
dc.typeArtículos de revistas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución